Table 1.
The most important demographic and clinical data of patients with inflammatory bowel diseases
| Ulcerative colitis (n = 10) | Crohn's disease (n = 10) | |
|---|---|---|
| Male:female | 2:3 | 2:3 |
| Age (years) (mean ± SD) | 50.6 ± 18.28 | 41.7 ± 13.1 |
| Duration of disease (years) (mean ± SD) | 7.3 ± 5.1 | 11.9 ± 10.7 |
| Indication for surgery | ||
| Treatment failure | 10 (100) | 2 (20) |
| Perforation | 0 | 1 (10) |
| Stenosis | 0 | 6 (60) |
| Fistulas | 0 | 1 (10) |
| Extent of disease | ||
| Ileum | 0 | 0 |
| Colon | 8 (80) | 5 (50) |
| Ileum and colon | 0 | 5 (50) |
| Rectosigmoid | 2 (40) | 0 |
| Medication | ||
| Methotrexate | 0 | 2 (20) |
| Infliximab | 6 (60) | 5 (50) |
| Azathioprine | 7 (70) | 6 (60) |
| Mycophenolate mofetil | 0 | 1 (10) |
| Adalimumab | 3 (30) | 4 (40) |
Values in parentheses are percentages.